Shares of SkinBioTherapeutics plc (LON:SBTX – Get Free Report) dropped 6.8% during mid-day trading on Wednesday . The company traded as low as GBX 12.15 ($0.16) and last traded at GBX 12.70 ($0.16). Approximately 883,025 shares were traded during mid-day trading, a decline of 5% from the average daily volume of 925,292 shares. The stock had previously closed at GBX 13.63 ($0.18).
SkinBioTherapeutics Stock Up 2.3 %
The company has a market cap of £32.95 million, a P/E ratio of -715.25 and a beta of 2.01. The company has a quick ratio of 10.01, a current ratio of 6.57 and a debt-to-equity ratio of 2.66. The company has a fifty day moving average of GBX 12.14 and a 200 day moving average of GBX 10.82.
About SkinBioTherapeutics
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Read More
- Five stocks we like better than SkinBioTherapeutics
- Where Do I Find 52-Week Highs and Lows?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What to Know About Investing in Penny Stocks
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
